Last Updated: November 13, 2026

ERGOTAMINE TARTRATE AND CAFFEINE Drug Patent Profile

Name: ERGOTAMINE TARTRATE AND CAFFEINE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Ergotamine Tartrate And Caffeine, and when can generic versions of Ergotamine Tartrate And Caffeine launch?

Ergotamine Tartrate And Caffeine is a drug marketed by Hikma and Pharmobedient and is included in two NDAs.

The generic ingredient in ERGOTAMINE TARTRATE AND CAFFEINE is caffeine; ergotamine tartrate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the caffeine; ergotamine tartrate profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ERGOTAMINE TARTRATE AND CAFFEINE?
What are the global sales for ERGOTAMINE TARTRATE AND CAFFEINE?
What is Average Wholesale Price for ERGOTAMINE TARTRATE AND CAFFEINE?

Summary for ERGOTAMINE TARTRATE AND CAFFEINE

US Patents:	0
Applicants:	2
NDAs:	2
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	3
Patent Applications:	3
DailyMed Link:	ERGOTAMINE TARTRATE AND CAFFEINE at DailyMed

Drug patent expirations by year for ERGOTAMINE TARTRATE AND CAFFEINE

Pharmacology for ERGOTAMINE TARTRATE AND CAFFEINE

Drug Class	Central Nervous System Stimulant Ergotamine Derivative Methylxanthine
Physiological Effect	Central Nervous System Stimulation

US Patents and Regulatory Information for ERGOTAMINE TARTRATE AND CAFFEINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma	ERGOTAMINE TARTRATE AND CAFFEINE	caffeine; ergotamine tartrate	TABLET;ORAL	040510-001	Sep 17, 2004		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Pharmobedient	ERGOTAMINE TARTRATE AND CAFFEINE	caffeine; ergotamine tartrate	TABLET;ORAL	040590-001	Sep 16, 2005		RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.